At Merck Serono, we have an enduring commitment and focus in our specialist therapeutic areas of oncology, neurodegenerative diseases, fertility and endocrinology, along with rheumatology as an emerging area of expertise. We also provide a portfolio of cardio metabolic care and general medicine products, especially in emerging markets where patient need remains high. Around the world, teams of dedicated employees work to discover, develop, manufacture and commercialize our prescription medicines, available in over 150 countries. We are internationally recognized as a biotechnology leader, with innovative and successful products along with a promising development pipeline. Our expertise in both biotechnology and pharmaceutical chemistry, combined with a profound understanding of disease in our focus therapeutic areas, enables us to take a flexible approach to finding the right compound to treat a specific disease. The capability to develop and manufacture new molecular entities of either type with equal success allows Merck Serono to exploit the full potential of the biological and chemical spheres at every stage of the drug development process. We truly believe that our focused expertise can make a real difference to people living with serious diseases. Not everything we do leads to a breakthrough, but we never lose sight of the human need that motivates us.